Bone Fractures

• EMA approval · 2024-09-16
  EMA Authorised: Bondronat (ibandronic acid) — Atnahs Pharma Netherlands B.V.

  EU marketing authorisation granted to Bondronat (ibandronic acid) for hypercalcemia, breast cancer with bone metastases, and bone-related fr…

• EMA approval · 2024-08-30
  EMA Authorised: Iasibon (ibandronic acid) — Pharmathen S.A.

  EMA authorised Iasibon (ibandronic acid) for hypercalcemia, prevention of bone fractures, and cancer-related indications involving metastati…

• EMA approval · 2020-11-20
  EMA Authorised: Zoledronic acid medac (zoledronic acid monohydrate) — medac Gesellschaft für klinische Spezialpräparate mbH

  The EMA authorised zoledronic acid monohydrate (Zoledronic acid medac) for use in fractures/bone-related conditions and cancer, under the ma…